Critic at Large

» disease/medicine and policy

Most Recent

Measuring PD-L1 levels was a great start. Now we need to quantify more protein biomarkers, assess the tumor mutational landscape, and examine immune cell signatures, too.


image: Body, Heal Thyself

Body, Heal Thyself

By Jason Liebowitz | September 1, 2015

Reviving a decades-old hypothesis of autoimmunity


image: Hurdles for Hearing Restoration

Hurdles for Hearing Restoration

By Bernd Fritzsch | September 1, 2015

Given the diverse cell types and complex structure of the human inner ear, will researchers ever be able to re-create it?

1 Comment

image: Control ALT, Delete Cancer

Control ALT, Delete Cancer

By Haroldo Silva, David Halvorsen, and Jeremy D. Henson | April 1, 2015

Treating cancer by shutting down the alternative lengthening of telomeres (ALT) pathway

1 Comment

image: The Challenges of Precision

The Challenges of Precision

By Adam Marcus | April 1, 2015

Researchers face roadblocks to treating an individual patient’s cancer as a unique disease.

1 Comment

image: Facing Down Emerging Viruses

Facing Down Emerging Viruses

By Michal Barski | February 1, 2015

A better knowledge of the pathogenesis of emerging zoonotic diseases is crucial if we want to prepare for “the next Ebola.”


image: Overspending on Overhead

Overspending on Overhead

By Viviane Callier | February 1, 2015

Federal research dollars are needlessly wasted as scientists spend more and more of their time trying to recoup operational costs.


image: A Matter of Size

A Matter of Size

By Scott McNeil | August 1, 2014

Erroneous characterization of nanomaterials can misinform the study of a new medicine’s safety and efficacy.


image: Psychiatry: An SOS Call

Psychiatry: An SOS Call

By Robert E. Becker | May 1, 2014

Social policies shaped the practice of psychiatry in the past. As the discipline becomes ever more scientific, the effects of social policy on patient well-being must not be ignored.


image: Fighting Cancer with Nanomedicine

Fighting Cancer with Nanomedicine

By Dean Ho | April 1, 2014

Nanotechnology-based therapeutics will revolutionize cancer treatment.


Popular Now

  1. Could Rapamycin Help Humans Live Longer?
  2. Renowned Physicist Stephen Hawking Dies
  3. Pupil Response to an Optical Illusion Tied to Autistic Traits
  4. John Sulston, Human Genome Project Leader, Dies